U.S. Sterilization Services Market Size, Share & Trends Analysis Report By Service Type (Contract Sterilization Services, Validation Sterilization Services), By Delivery Mode (Offsite, Onsite), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
UK Hypodermic Syringes And Needles Market Growth & Trends
The UK hypodermic syringes and needles market size is anticipated to reach USD 479.3 million by 2030, expanding at a CAGR of 16.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as the growing geriatric population, increasing prevalence of chronic disorders, and rising number of surgeries. Increasing demand for syringes for mass vaccination is the primary factor driving the demand for hypodermic syringes and needles. Moreover, an increasing number of needlestick injuries is expected to drive the market growth. According to a National Library of Medicine study published in April 2024, approximately 100,000 needlestick injuries occur annually in the UK.
Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.
Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.
UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.
UK Hypodermic Syringes And Needles Market Report Highlights
UK Hypodermic Syringes And Needles Market Growth & Trends
The UK hypodermic syringes and needles market size is anticipated to reach USD 479.3 million by 2030, expanding at a CAGR of 16.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as the growing geriatric population, increasing prevalence of chronic disorders, and rising number of surgeries. Increasing demand for syringes for mass vaccination is the primary factor driving the demand for hypodermic syringes and needles. Moreover, an increasing number of needlestick injuries is expected to drive the market growth. According to a National Library of Medicine study published in April 2024, approximately 100,000 needlestick injuries occur annually in the UK.
Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.
Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.
UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.
UK Hypodermic Syringes And Needles Market Report Highlights
- Based on product, the hypodermic syringes segment held the largest market share in 2023. This is attributed to the quick technical developments that increase patient comfort, safety, and effectiveness during medical procedures
- Based on end use, the hospitals segment dominated the market with the largest revenue share in 2023. This is due to their crucial role in maintaining a consistent and high demand for hypodermic needles and syringes, primarily due to the extensive number of medical procedures carried out
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service Type
1.2.2. Delivery Mode
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service Type Outlook
2.2.2. Delivery Mode outlook
2.3. Competitive Insights
CHAPTER 3. U.S. STERILIZATION SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for infection control in healthcare settings
3.2.1.2. Rise in surgical procedures and medical device use
3.2.1.3. Increasing regulatory requirements
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High operational costs
3.3. U.S. Sterilization Services Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. STERILIZATION SERVICES MARKET: SERVICE TYPE ESTIMATES & TREND ANALYSIS
4.1. Service Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Sterilization Service by Service Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Contract Sterilization Services
4.4.1.1. Contract sterilization services market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Validation Sterilization Services
4.4.2.1. Validation sterilization services market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. STERILIZATION SERVICES MARKET: DELIVERY MODE ESTIMATES & TREND ANALYSIS
5.1. Delivery Mode Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Sterilization Services by Delivery Mode Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Offsite
5.4.1.1. Offsite market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Onsite
5.4.2.1. Onsite market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. STERIS
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. MEDIVATORS Inc.
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Pall Corporation
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Ecolab
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. BD
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Thermo Fisher Scientific Inc.
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Merck & Co., Inc.
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. 3M
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. E-BEAM Services, Inc.
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Stryker
6.4.10.1. Company overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service Type
1.2.2. Delivery Mode
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service Type Outlook
2.2.2. Delivery Mode outlook
2.3. Competitive Insights
CHAPTER 3. U.S. STERILIZATION SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for infection control in healthcare settings
3.2.1.2. Rise in surgical procedures and medical device use
3.2.1.3. Increasing regulatory requirements
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High operational costs
3.3. U.S. Sterilization Services Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. STERILIZATION SERVICES MARKET: SERVICE TYPE ESTIMATES & TREND ANALYSIS
4.1. Service Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Sterilization Service by Service Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Contract Sterilization Services
4.4.1.1. Contract sterilization services market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Validation Sterilization Services
4.4.2.1. Validation sterilization services market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. STERILIZATION SERVICES MARKET: DELIVERY MODE ESTIMATES & TREND ANALYSIS
5.1. Delivery Mode Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Sterilization Services by Delivery Mode Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Offsite
5.4.1.1. Offsite market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Onsite
5.4.2.1. Onsite market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. STERIS
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. MEDIVATORS Inc.
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Pall Corporation
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Ecolab
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. BD
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Thermo Fisher Scientific Inc.
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Merck & Co., Inc.
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. 3M
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. E-BEAM Services, Inc.
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Stryker
6.4.10.1. Company overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives
